[HTML][HTML] Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities
YF Chen, J Li, LL Xu, MA Găman… - World Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
As an important treatment for acute myeloid leukemia, allogeneic hematopoietic stem cell
transplantation (allo-HSCT) plays an important role in reducing relapse and improving long …
transplantation (allo-HSCT) plays an important role in reducing relapse and improving long …
Effects of quercetin on ovarian function and regulation of the ovarian PI3K/Akt/FoxO3a signalling pathway and oxidative stress in a rat model of cyclophosphamide …
S Zheng, M Ma, Y Chen, M Li - Basic & Clinical Pharmacology …, 2022 - Wiley Online Library
To investigate the ability of quercetin to improve ovarian function and inhibit ovarian
oxidative stress through the PI3K/Akt/FoxO3a signalling pathway in a rat model of premature …
oxidative stress through the PI3K/Akt/FoxO3a signalling pathway in a rat model of premature …
The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo
SR Lin, CH Chang, MJ Tsai, H Cheng… - … in Chronic Disease, 2019 - journals.sagepub.com
Dipeptidyl peptidase IV (DPP-4), an incretin glucagon-like peptide-1 (GLP-1) degrading
enzyme, contains two forms and it can exert various physiological functions particular in …
enzyme, contains two forms and it can exert various physiological functions particular in …
A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia
AA van de Loosdrecht, S van Wetering… - Cancer Immunology …, 2018 - Springer
In elderly acute myeloid leukemia (AML) patients post-remission treatment options are
associated with high comorbidity rates and poor survival. Dendritic cell (DC)-based …
associated with high comorbidity rates and poor survival. Dendritic cell (DC)-based …
Hematopoietic stem cell transplantation and quality of life during the first year of treatment
ACB Marques, AP Szczepanik… - … latino-americana de …, 2018 - SciELO Brasil
Objective: to evaluate the quality of life of adult patients with hematological cancer
comparing Hematopoietic Stem Cell Transplantation modalities during the first year of …
comparing Hematopoietic Stem Cell Transplantation modalities during the first year of …
儿童异基因造血干细胞移植后细胞免疫重建的临床研究
宋娜, 孙鸣, 祁闪闪, 王卓, 杨李, 卢文婕… - 临床儿科 …, 2022 - jcp.xinhuamed.com.cn
目的探讨儿童异基因造血干细胞移植(allo-HSCT) 后免疫重建的临床特性. 方法选取2019 年7
月至2020 年10 月接受allo-HSCT 且临床资料完整的患儿为研究对象. 动态监测患儿移植后第0 …
月至2020 年10 月接受allo-HSCT 且临床资料完整的患儿为研究对象. 动态监测患儿移植后第0 …
[HTML][HTML] Trasplante de Células Tronco Hematopoyéticas y calidad de vida durante el primer año de tratamiento
ACB Marques, AP Szczepanik… - … Latino-Americana de …, 2018 - SciELO Brasil
Objective: to evaluate the quality of life of adult patients with hematological cancer
comparing Hematopoietic Stem Cell Transplantation modalities during the first year of …
comparing Hematopoietic Stem Cell Transplantation modalities during the first year of …
Qualidade de vida nos primeiros seis meses pós-transplante de células-tronco hematopoéticas
ACB Marques, SFFS Proença… - Texto & Contexto …, 2017 - SciELO Brasil
Objetivo: avaliar a qualidade de vida dos pacientes adultos com câncer hematológico
submetidos ao transplante de células-tronco hematopoéticas nos primeiros seis meses e …
submetidos ao transplante de células-tronco hematopoéticas nos primeiros seis meses e …
Top ten tips palliative care clinicians should know about caring for patients with hematologic malignancies
Hematologic malignancies differ in several important ways from solid organ cancers, and
warrant a unique approach to palliative care (PC) integration. As PC has moved upstream …
warrant a unique approach to palliative care (PC) integration. As PC has moved upstream …
Quality of life of patients with graft-versus-host disease (GvHD) post-hematopoietic stem cell transplantation
SFFS Proença, CM Machado, RCFP Coelho… - Revista da Escola de …, 2016 - SciELO Brasil
OBJECTIVE Assessing the quality of life of adult patients with hematological cancer in the
100 days after transplantation of hematopoietic stem cells and verifying whether the variable …
100 days after transplantation of hematopoietic stem cells and verifying whether the variable …